Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
64.57
+0.39 (0.61%)
Nov 21, 2024, 4:00 PM EST - Market closed
Utah Medical Products Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 15.26 | 16.64 | 16.47 | 14.79 | 10.8 | 14.73 | Upgrade
|
Depreciation & Amortization | 3.16 | 6.37 | 7.08 | 7.28 | 7.21 | 6.88 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | 0 | 0.02 | Upgrade
|
Stock-Based Compensation | 0.26 | 0.23 | 0.18 | 0.17 | 0.16 | 0.11 | Upgrade
|
Provision & Write-off of Bad Debts | -0.01 | -0.03 | 0.03 | 0.02 | -0.01 | 0.01 | Upgrade
|
Other Operating Activities | -0.83 | -0.69 | -0.4 | -0.09 | -0.03 | -0.4 | Upgrade
|
Change in Accounts Receivable | -0.17 | 2.27 | -0.51 | -1.09 | 0.62 | -0.74 | Upgrade
|
Change in Inventory | 0.76 | -0.67 | -2.35 | -0.49 | 0.92 | -1.69 | Upgrade
|
Change in Accounts Payable | 0.49 | -0.46 | 0.46 | -0.02 | -0.31 | 0.11 | Upgrade
|
Change in Other Net Operating Assets | -1.71 | -1.38 | 0.17 | 0.59 | 0.76 | -2.01 | Upgrade
|
Operating Cash Flow | 17.23 | 22.28 | 21.15 | 21.2 | 20.14 | 17.06 | Upgrade
|
Operating Cash Flow Growth | -23.88% | 5.36% | -0.26% | 5.29% | 18.06% | 1.32% | Upgrade
|
Capital Expenditures | -0.31 | -0.64 | -0.81 | -0.55 | -0.86 | -0.54 | Upgrade
|
Sale of Property, Plant & Equipment | 0.03 | - | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.01 | - | -0.01 | - | - | -21 | Upgrade
|
Investing Cash Flow | -0.29 | -0.64 | -0.82 | -0.55 | -0.86 | -21.54 | Upgrade
|
Issuance of Common Stock | 0.39 | 0.12 | 0.17 | 0.56 | 0.36 | 0.28 | Upgrade
|
Repurchase of Common Stock | -13.26 | - | -2.5 | - | -6.98 | -0.4 | Upgrade
|
Common Dividends Paid | -4.29 | -4.28 | -3.16 | -11.47 | -4.12 | -4.11 | Upgrade
|
Financing Cash Flow | -17.16 | -4.17 | -5.48 | -10.91 | -10.73 | -4.23 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.47 | 0.34 | -0.77 | -0.36 | 0.26 | 0.39 | Upgrade
|
Net Cash Flow | 0.24 | 17.82 | 14.08 | 9.38 | 8.8 | -8.33 | Upgrade
|
Free Cash Flow | 16.92 | 21.64 | 20.34 | 20.65 | 19.28 | 16.52 | Upgrade
|
Free Cash Flow Growth | -23.26% | 6.41% | -1.52% | 7.13% | 16.72% | 0.51% | Upgrade
|
Free Cash Flow Margin | 38.38% | 43.09% | 38.90% | 42.10% | 45.70% | 35.21% | Upgrade
|
Free Cash Flow Per Share | 4.74 | 5.95 | 5.58 | 5.64 | 5.25 | 4.42 | Upgrade
|
Cash Income Tax Paid | 5.05 | 4.83 | 4.97 | 4.62 | 3.19 | 5.3 | Upgrade
|
Levered Free Cash Flow | 13.46 | 17.65 | 18.77 | 17.14 | 16.85 | -7.64 | Upgrade
|
Unlevered Free Cash Flow | 13.46 | 17.65 | 18.77 | 17.14 | 16.85 | -7.64 | Upgrade
|
Change in Net Working Capital | 0.31 | -0.17 | 0.47 | 1.56 | -1.77 | 4.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.